No Data
No Data
Express News | DarioHealth Corp : TD Cowen Cuts Target Price to $3 From $5
TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $3
DarioHealth Buy Rating Affirmed: Strategic Growth and Path to Profitability
Earnings Call: DarioHealth Sees Strong Growth, Aims for Profitability by Next Year
DarioHealth Corp. (NASDAQ:DRIO) Just Reported And Analysts Have Been Lifting Their Price Targets
Earnings Call Summary | DarioHealth(DRIO.US) Q2 2024 Earnings Conference